
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV ‐2 mRNA ‐1237 vaccine in patients with solid tumors
Eudald Felip, Edwards Pradenas, Margarita Romeo, et al.
Molecular Oncology (2022) Vol. 17, Iss. 4, pp. 686-694
Open Access | Times Cited: 5
Eudald Felip, Edwards Pradenas, Margarita Romeo, et al.
Molecular Oncology (2022) Vol. 17, Iss. 4, pp. 686-694
Open Access | Times Cited: 5
Showing 5 citing articles:
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies
Amit Chhabra, George Bashirians, Christos J. Petropoulos, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101273-101273
Open Access | Times Cited: 12
Amit Chhabra, George Bashirians, Christos J. Petropoulos, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101273-101273
Open Access | Times Cited: 12
Real-World Data on Neutralizing Antibody and Safety of COVID-19 Vaccine against SAR-CoV2 Wild Type and Omicron Variant in Solid Cancer Patients
B. Chewaskulyong, Pattarapong Satjaritanun, Apichat Tantraworasin, et al.
(2024)
Open Access | Times Cited: 1
B. Chewaskulyong, Pattarapong Satjaritanun, Apichat Tantraworasin, et al.
(2024)
Open Access | Times Cited: 1
Humoral Response to SARS-CoV-2 Vaccine-Boost in Cancer Patients: A Case Series from a Southern European Cancer Center
Júlio Oliveira, Pedro Cruz, Tânia R. Dias, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1207-1207
Open Access | Times Cited: 1
Júlio Oliveira, Pedro Cruz, Tânia R. Dias, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1207-1207
Open Access | Times Cited: 1
Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients
B. Chewaskulyong, Pattarapong Satjaritanun, Thanika Ketpueak, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0310781-e0310781
Open Access
B. Chewaskulyong, Pattarapong Satjaritanun, Thanika Ketpueak, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0310781-e0310781
Open Access
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
Christopher W. Dukes, Marine Potez, Jeffrey E. Lancet, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 13-13
Open Access | Times Cited: 1
Christopher W. Dukes, Marine Potez, Jeffrey E. Lancet, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 13-13
Open Access | Times Cited: 1